Bayer AG
Business Model Analysis
How Bayer Makes Money
Annual Revenue: ~$51.5B
Bayer generates revenue primarily through Pharmaceuticals / Life Sciences / Agriculture, with roughly ~$51.5B in annual revenue.
Core Growth Engine: After a strategic review in March 2024 Bayer decided not to break itself up, keeping the three divisions together while it works on litigation and debt. Growth therefore has to come from inside: scaling Nubeqa, which rea...
Revenue Model & Pricing
Bayer runs two very different businesses plus a consumer brand portfolio. Pharmaceuticals spent ~$3.91 billion (EUR 3,456 million) on research and development in 2025 to develop and launch patented specialty medicines in oncology, cardiovascular and renal disease, women's health and radiology, and sells them to hospitals and specialist prescribers at high gross margins. Crop Science breeds hybrid seed, licenses biotech traits such as insect resistance and herbicide tolerance, and sells matching herbicides, fungicides and insecticides through dealer and distributor networks, with the Climate FieldView platform layered on top. Consumer Health sells over-the-counter brands through pharmacy, grocery and e-commerce channels. In 2025 Crop Science produced ~$24.4 billion (EUR 21,622 million) of sales, Pharmaceuticals ~$20.1 billion (EUR 17,829 million) and Consumer Health ~$6.56 billion (EUR 5,802 million).
Core Revenue Streams
Crop Science
about 47%Seeds, biotech traits, crop protection chemicals and digital farming produced ~$24.4 billion (EUR 21,622 million) of 2025 sales, led by Corn Seed and Traits at ~$8.08 billion (EUR 7,149 million).
Pharmaceuticals
about 39%Prescription medicines produced ~$20.1 billion (EUR 17,829 million) of 2025 sales, with Eylea at ~$3.51 billion (EUR 3,110 million), Nubeqa at ~$2.7 billion (EUR 2,385 million), Xarelto at ~$2.65 billion (EUR 2,344 million) and the Mirena family at ~$1.54 billion (EUR 1,366 million).
Consumer Health
about 13%Over-the-counter brands produced ~$6.56 billion (EUR 5,802 million) of 2025 sales across nutritionals, allergy and cold, pain and cardio, digestive health and dermatology.
Growth Strategy
After a strategic review in March 2024 Bayer decided not to break itself up, keeping the three divisions together while it works on litigation and debt. Growth therefore has to come from inside: scaling Nubeqa, which reached ~$2.7 billion (EUR 2,385 million) of sales in 2025, and Kerendia at ~$937 million (EUR 829 million); launching Lynkuet, Beyonttra and Hyrnuo; filing gadoquatrane in radiology; and bringing the icafolin-methyl herbicide to market from 2028, starting in Brazil. The cost side is the Dynamic Shared Ownership model, which Bayer says has removed about 12,000 positions and roughly half of its management positions and which underpins a ~$2.26 billion (EUR 2 billion) annual savings target for 2026. The supervisory board extended Bill Anderson's contract to March 31, 2029 in July 2025.
How Bayer Makes Money: FAQ
How does Bayer AG generate commercial revenue across its life sciences segments?
Bayer generates revenue through the wholesale distribution of agricultural seeds and traits (corn, soybean, cotton), crop protection chemicals (herbicides, fungicides, insecticides), prescription specialty pharmaceuticals, over-the-counter consumer healthcare products, and digital farming software (Climate FieldView).
What is the revenue breakdown across Bayer's three operating divisions?
In 2025 Crop Science generated ~$24.4 billion (EUR 21,622 million) of sales, about 47 percent of the group total, Pharmaceuticals ~$20.1 billion (EUR 17,829 million), about 39 percent, and Consumer Health ~$6.56 billion (EUR 5,802 million), about 13 percent. Group sales were ~$51.5 billion (EUR 45,575 million).
How does the Crop Science division monetize genetically modified seeds and traits?
Crop Science sells proprietary hybrid seeds (Dekalb corn, Asgrow soybeans, Deltapine cotton) paired with patented biotech traits (such as insect resistance and herbicide tolerance), earning premium per-bag seed pricing and technology licensing fees from farmers globally.
What is Climate FieldView and how does it drive digital agriculture revenue?
Climate FieldView is Bayer's digital farming platform. It combines satellite imagery, soil data and machine harvest data so growers can place seed and crop protection field by field, and Bayer sells it as a subscription alongside its seed and chemistry products.
How does Bayer monetize prescription specialty pharmaceuticals?
Bayer markets specialty medicines directly to hospitals, oncologists, cardiologists, and ophthalmologists, earning high gross margins on innovative branded drugs (Nubeqa, Kerendia) and collecting co-promotion revenues on Xarelto and Eylea.
What is Bayer's Consumer Health retail distribution model?
Consumer Health distributes OTC pain, allergy, and nutritional products through retail pharmacy chains, grocery supermarkets, convenience stores, and e-commerce platforms (Amazon, digital pharmacies) worldwide.
How does Bayer manage patent expirations on legacy blockbusters Xarelto and Eylea?
Xarelto sales fell 32.6 percent to ~$2.65 billion (EUR 2,344 million) in 2025 as generics spread in Europe and Japan, and Eylea slipped 5.9 percent to ~$3.51 billion (EUR 3,110 million). Bayer is offsetting that with Nubeqa, up 56.6 percent to ~$2.7 billion (EUR 2,385 million), and Kerendia, up 79.0 percent to ~$937 million (EUR 829 million), plus the launches of Lynkuet, Beyonttra and Hyrnuo.
What new crop protection product is Bayer bringing to market?
Bayer submitted registration applications in July 2025 for icafolin-methyl, a post-emergent herbicide for broad-acre crops with a mode of action new to its portfolio, in the European Union, the United States, Brazil and Canada. It expects launches from 2028 onward, starting in Brazil.
How does Bayer make money?
Bayer operates as a massive life sciences conglomerate, generating highly diversified revenue from prescription drugs (Xarelto), consumer health (Claritin), and massive global agricultural seeds and pesticides (Crop Science).
Related Monetization Mechanics
Compare revenue streams, unit economics, and business models
Explore Bayer
Core profile pages, founders and related research hubs for this company.